Sort
82,697 grants matching “vaccine development”
Consensus Gene-Based Immunogens in Rhesus Monkeys
$960,504Norman L Letvin · Duke University · P01 · FY2006 · AI
MATERNAL IMMUNIZATION FOR THE PREVENTION OF INFECTIONS
$960,487Baylor College Of Medicine · N01 · FY2000 · AI
B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution
$960,412Raiees Ahmad Andrabi · University Of Pennsylvania · R01 · FY2024 · AI
B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution
$960,412Raiees Ahmad Andrabi · University Of Pennsylvania · R01 · FY2025 · AI
Project 1 - Immune profiling of natural dengue virus infections
$960,378Eva Harris · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$960,276Richard K. Plemper · Georgia State University · R01 · FY2022 · AI
Novel Targets for Vaccine Therapy
$960,254Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
CLINICAL AND REGULATORY OPERATIONS CENTER
$960,200Social And Scientific Systems, Inc. · N01 · FY2000 · AI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION
$960,145Kathy L Rowlen · Indevr, Inc. · R44 · FY2014 · AI
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$960,045Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Novel Immunoprophylaxes against Clostridium difficile Infection
$960,005Hanping Feng · University Of Maryland Baltimore · U19 · FY2016 · AI
A safety switch for an effective HIV-1 vaccine
$960,000Michael R. Farzan · Scripps Florida · DP1 · FY2020 · DA
A safety switch for an effective HIV-1 vaccine
$960,000Michael R. Farzan · Scripps Florida · DP1 · FY2018 · DA
A safety switch for an effective HIV-1 vaccine
$960,000Michael R. Farzan · Scripps Florida · DP1 · FY2019 · DA
A safety switch for an effective HIV-1 vaccine
$960,000Michael R. Farzan · Scripps Florida · DP1 · FY2017 · DA
A safety switch for an effective HIV-1 vaccine
$960,000Michael R. Farzan · Scripps Florida · DP1 · FY2021 · DA
cGMP signalling in Plasmodium intracellular development
$960,000Purnima Bhanot · Rutgers, The State University Of New Jersey-Rbhs-New Jersey Med · · FY2012 · BIO
Baylor College of Medicine Clinical Trial Unit
$959,712William Thomas Shearer · Baylor College Of Medicine · UM1 · FY2012 · AI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines
$959,574Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AI
Antibody-based Protection against Flavivirses
$959,574Michael S. Diamond · Washington University · R01 · FY2019 · AI
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
$959,550Jonah B. Sacha · Oregon Health & Science University · R01 · FY2020 · AI
Discovery and Translational Core Services
$959,473Gerald A Beltz · Harvard Medical School · U19 · FY2017 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2022 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2023 · AI
Global HIV/AIDS Vaccine Enterprise
$959,345National Institute Of Allergy And Infectious Diseases · Y01 · FY2016 · AI